The present invention relates to the use of N-aminoimidazole or N-aminoimidazole-thione derivatives as cytoprotective compounds in vitro and in vivo and for the treatment or prevention of cell death mediated disorders and/or GSK-3 mediated disorders or processes.

 
Web www.patentalert.com

< Compositions of an Orally Active 1,2,4-Oxadiazole for Nonsense Mutation Suppression Therapy

> Aspirin-Triggered Lipid Mediators

> Method of delaying the onset of clinically definite multiple sclerosis
~ 00525